Bayer Oncology Public
This page contains information about Bayer's medicines only and is intended for the UK general public and patients.
By using the list below, you can find links to the Electronics Medicines Compendium (eMC), a resource providing information about all medicines available in the UK. Through this resource, you'll find links to the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) for all our cancer medicines.
Please note that this information is specific to the UK and is not intended to replace the advice of a qualified doctor.
Reporting adverse events and quality complaints
This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the https://yellowcard.mhra.gov.uk or search MHRA Yellow Card in Google Play or Apple App Store.
You can also report side effects and quality complaints to Bayer Plc. Further information is available on the "contact" tab at www.bayer.co.uk.
By reporting side effects you can help provide more information on the safety of this medicine.